Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
Patients enrolled from each center according to confirmed criteria specified in cooperative
scheme are recieved induction and consolidation chemotherapy with microtransplantation .
Observe the remission rate and 2-year disease-free survival (DFS) and overall survival(OS)
rate.